Variant report
Variant | nsv968564 |
---|---|
Chromosome Location | chr9:11479707-11494344 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189597593 | chr9:11481801-11481802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182120279 | chr9:11481848-11481849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142129755 | chr9:11481906-11481907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565785459 | chr9:11481919-11481920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150741410 | chr9:11481958-11481959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551699249 | chr9:11481966-11481967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571797179 | chr9:11481972-11481973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139060201 | chr9:11481986-11481987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs370138968 | chr9:11482046-11482047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573954969 | chr9:11482050-11482051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185641130 | chr9:11482055-11482056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552919014 | chr9:11482066-11482067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573015269 | chr9:11482119-11482120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545467194 | chr9:11482120-11482121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371914524 | chr9:11482137-11482138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7875355 | chr9:11482159-11482160 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs577761727 | chr9:11482166-11482167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543396601 | chr9:11482179-11482180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563612270 | chr9:11482216-11482217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574317011 | chr9:11482219-11482220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535017281 | chr9:11482227-11482228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs147641468 | chr9:11482304-11482305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528230932 | chr9:11482315-11482316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551435779 | chr9:11482324-11482325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs116919440 | chr9:11482325-11482326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112692018 | chr9:11482326-11482327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569771919 | chr9:11482357-11482358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535503553 | chr9:11482367-11482368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs373246740 | chr9:11482396-11482397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7860367 | chr9:11482402-11482403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7860368 | chr9:11482408-11482409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79317832 | chr9:11482413-11482414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567639866 | chr9:11482415-11482416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369383862 | chr9:11482418-11482419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552982203 | chr9:11482430-11482431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566505109 | chr9:11482460-11482461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538800897 | chr9:11482488-11482489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140566329 | chr9:11482571-11482572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs59185297 | chr9:11482584-11482585 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs549040063 | chr9:11482590-11482591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543608581 | chr9:11482594-11482595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs375683624 | chr9:11482602-11482603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574002061 | chr9:11482625-11482626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs201611336 | chr9:11482630-11482631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542929281 | chr9:11482638-11482639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs13299523 | chr9:11482648-11482649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190100698 | chr9:11482694-11482695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs62552537 | chr9:11482695-11482696 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs372395384 | chr9:11482700-11482701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557068817 | chr9:11482736-11482737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11481800-11482200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr9:11482200-11485800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr9:11485800-11486200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr9:11485800-11487400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr9:11486200-11490600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
6 | chr9:11487400-11489000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr9:11489000-11492200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr9:11490600-11490800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
9 | chr9:11491200-11492000 | Enhancers | Fetal Heart | heart |
10 | chr9:11492000-11492800 | Weak transcription | Fetal Heart | heart |
11 | chr9:11492800-11493000 | Enhancers | Fetal Heart | heart |